Stocks To Buy Now Blog

All posts by Christopher

The Blockchain Futurist Conference, Together With ETHToronto, Bring Blockchain Technology and Cryptocurrency to Real Life

The most crypto enabled conference in the world returns to Toronto, Canada Blockchain Futurist Conference, Canada’s largest crypto and blockchain event, combined with ETHToronto, the official Hackathon of the Blockchain Futurist Conference, is coming back to Toronto this August 8-10, 2022 for its fourth year. With only a short time until this flagship event, along with the announcement about the newly added keynote speaker Vitalik Buterin, inventor of Ethereum, the excitement among the blockchain and cryptocurrency community is rapidly growing. Here’s how the conference will be crypto and blockchain enabled for 2022 so far: The conference has introduced a multitude of digital payment methods. Untraceable has partnered with Euka Pay to accept BTC, ETH, and USDT as payment for online tickets. Untraceable has also partnered with FLEXA to set-up vendors with payment processors to accept crypto onsite including helicopter rides, food trucks, tickets, and marketplace. They are bringing back the Futurist Crypto Marketplace where Toronto based vendors will be able to sell their merchandise and learn how to accept crypto payments for their business beyond the 3 day conference.  Anyone looking to sell their merchandise and accept crypto as payment should reach out to the team. For vendors, businesses, and newbies who want to start using cryptocurrency, Futurist’s Blockchain Bootcamp is the perfect learning platform, offering education on the in-and-outs of crypto and blockchain technology. Helicopter rides, provided by FlyGTA, are one of the top activations where attendees can purchase rides around Toronto using crypto. Futurist will have 3 NFT galleries throughout the venue where attendees can bid and purchase NFTs directly on-site, this is organized in partnership with NFTGoat. NFTs will be provided by the company Ribbon, creating recognition and exclusive NFTs to all those who helped make the event possible, including volunteers, staff, and key partner organizations. For the 4th year, Untraceable brings back their event-wide gamification designed to incentivize attendees to engage within the conference. Attendees receive points for actions such as visiting exhibitor booths, attending speaking sessions, and interacting with experiences around the venue. These points can be exchanged for Untraceable tokens called UNNY. Built on the polygon network, UNNY is a real-life engagement token designed to drive real-life actions in person. Over 10 pop-ups will be activated onsite for attendees to purchase experiential activations with the conference’s native token UNNY powered by the Flexa network. This is just a snapshot of the creative activations to bring blockchain technology and cryptocurrency to real life at the 2022 Blockchain Futurist Conference. The event will be a larger-than-life experience, a future world within a conference. Gamers, programmers, hackers, startups, and more can test their technology before sending it out to the real world. Unique technologies and innovations will evolve on the floor of the Blockchain Futurist Conference. In 2019, the team successfully performed live tracking of their produce from Farm to Table at the conference – showcasing new supply chain technology, and even the conference Insurance documents are also added to the blockchain to make it immutable. Tickets are selling fast and it is time to grab your access to the conference. For those who are unable to attend the in-person event, the conference will be live in the Metaverse through Cryptovoxels. The future is almost here! See you in August! To learn more, please visit https://www.futuristconference.com. To learn more about the ETHToronto event, please visit https://www.ethtoronto.ca. Apply to showcase your NFTs for free: https://ibn.fm/ElDkF.

Kronos Advanced Technologies Inc. (KNOS) Offers Best Air-Purification Devices in Growing Market

  • The indoor air quality solution market is projected to see a CAGR of 6.30% from 2021–2025
  • EPA reports that a growing body of scientific evidence has indicated that the air within homes and other buildings can be more seriously polluted than outdoor air
  • Kronos air purifiers destroy the widest range of pollutants, including viruses and VOCs
With a global pandemic capturing worldwide attention and health concerns becoming increasingly important, indoor air quality is coming under increased scrutiny. A recent report projects the indoor air quality market will see significant growth in the coming years (https://ibn.fm/SgtXP), a forecast that reinforces the commitment of Kronos Advanced Technologies (OTC: KNOS) to provide the best air-purification devices and products on the market. “According to the research report ‘Indoor Air Quality Solutions Market by Product and Geography — Forecast and Analysis 2021–2025,’ the market will witness a YOY growth of 3.23% in 2021 at a CAGR of 6.30% during the forecast period,” a recent PRNews report stated. “The expanding variety of pollutants in the region is one of the primary factors driving market expansion. The number of regulations and regulatory agencies, such as the United States Environmental Protection Agency (‘EPA’), is also growing to support the market’s expansion.” In fact, the EPA recently reported that “in the last several years, a growing body of scientific evidence has indicated that the air within homes and other buildings can be more seriously polluted than the outdoor air in even the largest and most industrialized cities” (https://ibn.fm/uVwa7). Another EPA report states that “Americans, on average, spend approximately 90 percent of their time indoors, where the concentrations of some pollutants are often two to five times higher than typical outdoor concentrations. . . . Indoor concentrations of some pollutants have increased in recent decades due to such factors as energy-efficient building construction (when it lacks sufficient mechanical ventilation to ensure adequate air exchange) and increased use of synthetic building materials, furnishings, personal care products, pesticides, and household cleaners” (https://ibn.fm/0px85). These compelling reports don’t mention the threat of viruses, which have only become more of a focus with the COVID-19 global pandemic. Clearly, the need for options to clean indoor air is becoming more urgent. Enter Kronos Advanced Technologies. This innovative company is committed to offering the highest-quality air-purification devices and products available. The company’s patented technology destroys harmful particles and collects them on easy-to-wash collecting plates, reducing the risk of harmful particles entering the lungs (https://ibn.fm/8N32T). “Think of your Kronos Air Purifier as the bionic lung for your house,” the company stated, noting that Kronos purifiers destroy the widest range of pollutants, including viruses and VOCs. “It effectively filters particles down to a tiny 0.0146μm (14.6 nanometers), which is far beyond the 0.3μm (3 microns) that a traditional HEPA does. By choosing Kronos, you have a cutting-edge, high-quality home air purifier that contributes to a happier and healthier planet.” For more information, visit the company’s website at www.KronosATI.co. NOTE TO INVESTORS: The latest news and updates relating to KNOS are available in the company’s newsroom at https://ibn.fm/KNOS

Nowigence Inc. (NOWG) Partners with Leader in India CSR Space to Grow Market, Benefit Society

  • Nowigence and EquiPPP Social Impact Technologies have entered an agreement to strengthen the CSR industry in India
  • The purpose is to connect donors and service organizations to improve the lives of the underprivileged in India
  • Nowigence is changing the data-gathering landscape with its Pluaris(TM) platform
Nowigence (OTCQB: NOWG), the SaaS technology company behind Pluaris, a comprehensive and turnkey AI knowledge engine, is expanding its footprint and presence in India. The company announced that it has signed a memorandum of understanding with EquiPPP Social Impact Technologies Ltd. (NSE: EQUIPPP) (https://ibn.fm/lkByC). The two companies are creating a mutually beneficial strategic business alliance. According to the agreement, EquiPPP, a Hyderabad-based technology company, will support Nowigence’s business development efforts by promoting Nowigence products in India. In return, Nowigence, which is tailoring its core machine learning and natural language processing engine to develop IT and ITeSaaS (information technology enabled software as a service) products for corporate social responsibility (“CSR”) activities, will grant EquiPPP exclusive marketing rights for these CSR products in India. “We are happy to partner with EquiPPP to deliver value in the growing CSR market while benefiting society at large,” said Nowigence CEO Anoop Bhatia. “We are excited to jointly bring technology into the social programs space. Together, we hope to make a significant difference in our collective social responsibility connecting donors and service organizations to improve the lives of the underprivileged.” Nowigence is changing the data-gathering landscape with its Pluaris(TM) platform, a comprehensive, ready-to-use artificial intelligence (“AI”) offering that delivers the combined power of an intelligent reader and a smart search engine. The app reads and analyzes public and private data sources for relevant content, in real time, on any topic and for any reason. EquiPPP is engaged in IT and ITeSaaS, providing software services and offering a digital platform that supports and allows stakeholders to collaborate in implementing CSR projects. The agreement between the two companies comes at an ideal time. India is leading the way in the CSR space, requiring top Indian companies with annual revenues of more than $140 million, assets of more than $70 million, or net benefits exceeding $700,000 to spend 2% of their normal net benefits on CSR initiatives annually. The partnership dovetails nicely with this regulation, allowing EquiPPP to offer unique services ideally suited for this market. “As part of our joint business development endeavor, we shall assist the top Indian companies to not only research programs for CSR but also create a transparent, unbiased and intelligent process connecting corporations, citizens, domain experts, NGOs and philanthropists with the Indian government,” said EquiPPP CEO Mahesh Ramachandran, MD. Nowigence is an innovative software as a service (“SaaS”) company, focused on developing and bringing to market Pluaris, its comprehensive, ready-to-use artificial intelligence platform. By integrating state-of-the-art data-processing techniques in an intuitive interface at an affordable subscription price, Pluaris puts the power of data science into the hands of consumers. For more information, visit the company’s website at www.Nowigence.com. NOTE TO INVESTORS: The latest news and updates relating to NOWG are available in the company’s newsroom at https://ibn.fm/NOWG

Flora Growth Corp. (NASDAQ: FLGC) Anticipates Continued Growth for Cannabis Operations Under New Colombian Administration

  • Flora Growth is a cannabis cultivator and distributor with a base of operations in Colombia’s fertile growing climate, capable of feeding the company’s expanding international supply chain
  • Colombia has undergone a number of regulatory changes in recent years as it emerges from the shadows of years-long drug wars and embraces a growing global acceptance of cannabis products
  • The South American country voted in a new presidential administration in June, and Flora Growth is applauding the president-elect’s continued openness to international cannabis trade
  • Flora Growth announced significant revenue growth during its year-end financial reporting in May, and the company stated it expects another 288 to 400 percent increase in revenues during the current year
Following nationwide elections that marked a historic change in Colombia’s presidency as well as its people’s social policy aspirations, emerging cannabis brand builder Flora Growth (NASDAQ: FLGC) is expressing optimism for its market opportunities, which are based on a growing cannabis cultivation operation in the South American country. Longtime legislator Gustavo Petro, a sitting senator and previously Mayor of Bogota, was declared Colombia’s chief executive-elect June 19 after his remaining opponent in a runoff election conceded that Petro had won the majority of the vote in an orderly transfer of authority (https://ibn.fm/KBkqK). Flora Growth enjoyed explosive energy in building an international supply chain for its cannabis products under the progressive drug policy changes instituted by outgoing President Ivan Duque’s administration, and the company anticipates Petro’s approach to the market’s opportunities will further open doors for its operations. “We would like to congratulate President-Elect Gustavo Petro on his victory and we look forward to working with the new government to continue Colombia’s progressive momentum in the global cannabis industry,” Flora Growth Chairman and CEO Luis Merchan stated in a recent news release (https://ibn.fm/GpQ5t). “We are encouraged by President-Elect Petro’s stance on seeing Colombia become a leader in the legal cannabis industry and we are hopeful for progressive legislation that will allow Colombia to create a safe environment for cannabis consumption domestically — potentially leading to a recreational market in the country,” Merchan added, while observing that Colombia’s environmental and labor conditions are ideal for building successful international commerce. Petro signaled his support of the industry last year when he stated, “The possibility of legal exportation of marijuana for recreational and medicinal purposes through licenses from the national government has friends with political power in Colombia. If Colombia does not get its act together, we’re going to lose that business” (https://ibn.fm/uvgsd). Flora Growth operates a 100-hectare (about 247-acre) cultivation facility known as Cosechemos in the heart of Colombia’s green grower-friendly climate. From its cultivation, extraction and isolation operations at the city of Bucaramanga, much of its product goes to its GMP-certified processing facility for beauty, phytotherapeutic and nutraceutical products in the nation’s capital, Bogotá. The company’s license applications with Colombia’s food and drug regulatory body have included more than 20 cannabinoid-infused food and beverage products, such as juices, sparkling seltzers, gummies, chocolates, ghee butter, and healthy snack foods, that prioritize natural ingredients and value-chain sustainability (https://ibn.fm/3vI4W). “While approximately 90% of Flora’s forecasted revenue is expected to be derived outside of Colombia, we see Colombia as particularly well suited both for production of high-quality, cost-advantaged cannabis and the manufacturing of cannabinoid-derived medical formulations that can be sold domestically and internationally,” Flora’s Chief Commercial Officer Jason Warnock added in the company news release. Year-end financial results announced in May reported annual revenue of about $9 million — a “significantly higher” amount than the company reported a year earlier before Colombia’s change in its drug product laws went into effect and Flora launched its IPO on the Nasdaq Capital Market. And the company stated at the time that it expects revenues to grow another 288 to 400 percent during the current year (https://ibn.fm/TpBLQ). For more information, visit the company’s website at www.FloraGrowth.com. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

No Debt and a Lot of Money Sets Golden Matrix Group Inc. (NASDAQ: GMGI) Apart as It Sets Sights on ESports Too

  • GMGI a standout differentiated in Benzinga’s Listmakers Series: ESports
  • Golden Matrix will be launching a new P2P ESports betting platformd
  • GMGI is eyeing new accretive acquisitions to extend its string of nearly 4 years of consecutive profitable quarters
Companies are usually willing to open their bank accounts for naming rights. For instance, FedEx is paying $7.5 million per year to have their name on the home field of the Washington Commanders. New tech brands are changing the game. In November 2021, Crypto.com agreed to pay $700 million to see the iconic Staples Center re-branded as Crypto.com Center for the next 20 years ($35 million/year). At the outset of Benzinga’s Listmakers Series: ESports, held June 22, 2022 featuring Golden Matrix Group (NASDAQ: GMGI), United Esports, and other heavy hitters in digital gaming, the event opened with a discussion on industry momentum that included cryptocurrency exchange FTX shelling out $210 million for the naming rights to esports organization TSM for the next 10 years. That’s nearly three times as much FTX pays each year for naming rights to the home arena for the Miami Heat of the National Basketball Association. Welcome to the digital revolution and the emergence of electronic sports into North America. Golden Matrix Group is differentiated from most companies involved in the conference insomuch that it is not an ESports team. Rather it is a leading provider of turnkey and white label gaming platforms, including Esports technology and gaming content. Golden Matrix built a name for itself with its business-to-business (“B2B”) platform, comprised of its GM-X system and the recently successful launched new GMX-Ag (aggregate) platform regarded as the industry standard, granting access to over 10,000 games from more than 25 game providers. The Las Vegas-based company is an expert in player loyalty, which allows operators to control churn and generate additional revenue from an existing player, rather than increasing expenses for new player acquisition. As of the end of the second quarter, GMGI supports over 635 unique casino operations and over 6.5 registered million players. Late in 2021, GMGI made its initial foray into the business-to-consumer (“B2C”) marketplace, with the acquisition of 80% of Ireland-based contest operator RKings. RKings owns and operates raffles for participants in Ireland and the United Kingdom. Contest prizes are frequently for big ticket items, such as automobiles, boats, exotic vacations, and more. In March, GMGI applied for a permit to operate the contests in Mexico, the next leg in international expansion for the RKings platform. With a bit of a chuckle during an interview with Benzinga’s Zunaid Suleman, Golden Matrix Group CEO Brian Goodman effectively said, “Let’s call it what it is; we’re a ‘gambling’ company, not a ‘gaming’ company.” In industry nomenclature, it is generally considered PC to not say “gambling,” even when talking about online casino games or betting on game outcomes. There are many reasons for that, including strict regulations on what is indeed a game of skill versus a game of chance and geolocation factors regarding where licenses are mandatory for operations. Goodman has been a popular figure lately, also interviewed on the latest episode the Bell2Bell podcast. There is growing choir of voices about the future of ESports gambling, but, as Goodman discusses with Suleman, there are a lot of nuances to keeping bets fair and an honest marketplace. For now, his company has built out a system for peer-to-peer (“P2P”) betting system along with some built-in games for ESports players that will be launching soon. P2P betting is legal throughout the U.S., although there are considerations for money transfers under the Wire Act that must be followed. P2P has been trumpeted for its massive potential to eliminate the “house” and creating wager unlimited wager scenarios so that bettors don’t feel like the deck is always stacked in the house’s favor. That will be a solid addition to a company that has graduated from the OTC Pink Sheets to OTCQX Best Market to NASDAQ Capital Markets in about 9 months. While many companies languished through the COVID-19 pandemic, GMGI maintained its string of profitability, which has now been extended to 15 straight quarters. From beginning of this fiscal year, the company began realizing the benefits of the RKings acquisition, which further bolstered the top and bottom lines. Revenue for the quarter ended April 30, 2022, was $8.48 million, up 221% from $2.64 million in the year prior quarter. Net income was $586,984, a gain of 359% from $127,986 in a same period a year earlier. Shareholders’ equity of GMGI of rose 37% year-over-year to $26 million from $18.93 million. The company has no debt and finished the quarter with cash and cash equivalents of $15.81 million. “We’re rolling out some new operators every week…what we’ve told the market already is that the core business will continue to grow, but we will also acquire some accretive profitable businesses in a similar line to what we do,” said Goodman. He opined that he is hopeful the company will make some acquisitions in the coming months to scale the business. “We’ve always returned value to shareholders, and we continue to grow every quarter. We don’t burn money. We’re a solid investment for people who want to get in and ride along with something that is growing,” Goodman added. For more information, visit the company’s website at www.GoldenMatrix.com. NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) (FRA: 6BC0) Set to Meet 2022 Revenue Target

  • In 2021, Eat Well acquired Belle Pulses Ltd. Sapientia Technologies Inc. and a 51% stake at Amara Organic Foods
  • These acquisitions saw a 1,082% growth in the company’s assets for the 2021 financial year and a 320% revenue growth for Amara
  • With the plant-based foods market projected to be valued at $162 billion by 2030, Eat Well expects to capitalize on this growth through M&As and strategic partnerships with key players in the industry
  • Eat Well is confident that with the foundation laid down so far, it is poised to achieve $100 million in revenue for 2022
At the close of the 2021 calendar year, Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) (FRA: 6BC0) was regarded as “One to Watch.”  This mainly stemmed from its aggressive market expansion plans, vertical integration, and the bolstering of its leadership (https://ibn.fm/tFGDP). Over the course of the year, Eat Well proved how well its management was at sourcing, financing, and building successful companies. Together, these individuals had financed and invested in early-stage venture companies for over 25 years. The experience would allow Eat Well to acquire Belle Pulses Ltd., 100% of Sapientia Technologies Inc., and 51% shares at Amara Organic Foods. Consequently, the acquisitions would see the addition of revenue channels for Eat Well, setting the company on the road to targeting approximately $100 million in revenue for the 2022 financial year. On June 10, 2022, Eat Well released its fourth-quarter and full-year financial results for 2021, marking a 1,082% growth in assets from the previous year. Amara would post the highest revenue growth at 320% from 2020, mainly influenced by its “toddler melts” product launch across North American retail. Given its performance, Eat Well’s management expressed its optimism for 2022, citing the growth of the plant-based foods market and how well-positioned its portfolio companies are to take advantage of this growth (https://ibn.fm/UKidY). “We have laid a strong foundation within the Eat Well Group investment platform, and we are very enthusiastic about the trajectory of our portfolio,” noted Marc Aneed, Eat Well’s Director, President, and Chief Executive Officer (“CEO”). “Our portfolio companies are well positioned to capture global pulse demand and accelerate the scale of their better-for-you consumer products for years to come,” he added. It is projected that the plant-based foods market will comprise up to 7.7% of the global protein market by 2030, valued at $162 billion, up from $29.4 billion in 2020. Many analysts have even likened the food tech market to the early days of the internet in that plant-based foods represent a worldwide secular trend of steady growth and potential that will revolutionize how society functions and people experience nutrition. Through Eat Well’s aggressive yet strategic merger and acquisition (“M&A”) transactions, the company is positioning itself to take advantage of this shift in consumer preference and the growing plant-based industry. As of December 2021, Amara’s revenues had grown by over 400% since the beginning of the year, drawing media coverage from outlets such as TechCrunch and Forbes and highlighting the tremendous potential for growth for Eat Well Investment Group. Today, Eat Well supplies big companies such as Beyond Meat, Nestle, Ingredion, and General Mills, among others. As time progresses, it looks to strengthen its distribution network and its relationship with strategic partners to create value for its shareholders with its projected $100 million revenue target for 2022. For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

New Agreements Signed Between Lexaria Bioscience Corp. (NASDAQ: LEXX) and BevNology LLC; Pre-IND Meeting Request Filed with FDA

  • The two companies signed a manufacturing operating agreement and a commercial agreement
  • Lexaria sent a pre-IND meeting request letter to the US FDA and plans to file the full IND application in late 2022/early 2023
  • The FDA has acknowledged Lexaria’s pre-IND request and responded with conditions prior to the target date of July 30, 2022
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has recently announced signing two agreements with BevNology LLC, the product and development arm of InterContinental Beverage Capital (“IBC”), operating its state-of-the-art lab and manufacturing facility just outside of Atlanta, Georgia. This announcement only furthers Lexaria’s leverage of the market, with the company’s patented DehydraTECH(TM) technology having already been embraced by several consumer packaged goods brands, with availability in over 7,000 stores throughout the United States and Japan, including direct-to-consumer online retail portals (https://ibn.fm/gLQzN). The manufacturing operating agreement expands the production capabilities of Lexaria’s growing list of business-to-business clientele interested in purchasing DehydraTECH-powered active ingredients for packaged-goods brands. The new, state-of-the-art processing facility built by BevNology is operational, increasing and broadening production capabilities. This facility is currently serving Lexaria’s corporate clientele, with new equipment specific to DehydraTECH already installed. The second agreement is a commercial license, empowering BevNology to offer the DehydraTECH products with active ingredients derived from hemp, including cannabidiol (“CBD”), under BevNology and partnered brands. The agreement is non-exclusive for powdered DehydraTECH formulations. For liquid formulations, the non-exclusivity is limited in the United States only, requiring certain minimum fee payments to maintain rights. Lexaria will receive royalties from BevNology for the utilization under this license, with exclusion only affecting Japan, the Republic of Korea, and the People’s Republic of China. “These agreements build on a long-standing and very successful product development consulting relationship between Lexaria and the expert scientists and personnel at BevNology.” Lexaria CEO Chris Bunka said. “BevNology’s formulation and production capabilities are class leading, and we are confident that our new relationship with our trusted partner will propel new and exciting growth opportunities for both companies.” In other recent news, Lexaria has filed its pre-IND meeting request letter with the United States Food and Drug Administration (“FDA”) to initiate communication with the FDA regarding Lexaria’s development of the company’s DehydraTECH-CBD for potential hypertension treatment. The FDA has responded to and confirmed the company’s letter, with a target date of July 30, 2022, and disclosed the conditions in which Lexaria must meet prior to the meeting. Lexaria anticipates filing the full IND application in late 2022/early 2023 (https://ibn.fm/MpKmr). “We are excited to take this important first regulatory step with the FDA for the development of our DehydraTECH-CBD for the treatment of hypertension,” stated John Docherty, President of Lexaria. “Submission of this request letter initiates formal communication with the FDA regarding our IND clinical trial plans in order to help define the critical path for clinical development and marketing approval of our potentially very significant new hypertension therapeutic.” The hypertension treatment market is valued at approximately $28 billion per year and is expected to grow as one of the world’s top health problems as a subset of a larger heart disease market (https://ibn.fm/sIjQJ). There are over 1.1 billion people in the world suffering from hypertension, with fewer than 1 in 4 having successful control over it. The potential market size increases if an affordable drug were available with few or no side effects. Some reports indicate drugs for hypertension and related conditions are among the highest-selling category of drugs in the world (https://ibn.fm/oAxXN). For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

Odyssey Health, Inc. (ODYY) Taps Military Advisors to Address Target Market for PRV-002 Concussion Drug

  • Odyssey Health is a medical company focused on developing medical products for conditions with unmet needs, one of which is concussion
  • Currently, concussions do not have an FDA-approved treatment
  • Soldiers form a significant population of people who frequently experience multiple concussions throughout their career
  • Concussion has only recently received greater attention as different parties seek to understand the condition and possible treatments
  • Odyssey is at the forefront of this pursuit for treatment and has developed the PRV-002 drug candidate that it intends to use on the military as part of a Phase II clinical trial
  • The company announced the formation of a Military Advisory Board to help in this journey
According to a study by the Business Development Bank of Canada (“BDC”), 86% of businesses with an advisory board say it has had a substantial impact on their operations. In addition, the study showed that companies with an advisory board witnessed 24% higher annual sales and 18% higher productivity than businesses without one (https://ibn.fm/K437C). Looking to tap into these favorable statistics as well as to better understand one of its important target markets, the military, Odyssey Health (OTC: ODYY), a medical company focused on unique, life-saving medical products that offer clinical advantages to conditions with unmet needs, announced the formation of a Military Advisory Board (https://ibn.fm/LJwwD). The board, which comprises associated military contacts (retired members of the U.S. armed forces who previously held leadership positions), was formed to gain experience and information that will provide crucial insights into traumatic brain injuries (“TBI”) and their effects on those who sustain TBI. “TBI in general, and mild TBI in particular, is considered a ‘silent epidemic’ because many of the acute and enduring alterations in cognitive, motor, and somatosensory functions may not be readily apparent to external observers,” an article published in the National Institutes of Health (“NIH”)’s National Library of Medicine website reads (https://ibn.fm/0P7nE). The article goes on to note that approximately 80% of all TBI cases are categorized as mild (“mTBI”). Still, these approximations are considered underestimates “because they do not account for incidents of TBI in which the person does not seek medical care.” Concussions are frequent in contact sports, with soldiers making up another significant proportion of people who frequently sustain these injuries multiple times over their careers. Latest statistics show that over 430,000 U.S. service members were diagnosed with a TBI from 2000 to 2020 (https://ibn.fm/OpnXq), with 75-83% of these cases having been categorized as mild (“mTBI”) (https://ibn.fm/PhTRQ). In addition, one analysis notes that one in six soldiers returning from deployment in Iraq met the criteria for concussion. For a long time, however, concussions did not receive the necessary urgency and attention to understand the underlying mechanisms of mild brain trauma and device potential therapeutic interventions. In fact, a New York Times article notes, many soldiers used to shrug off ailments that began following blasts – headaches, dizzy spells, numbness in their arms, dehydration, fatigue, and persistent ringing in their ears – only to later develop even more severe symptoms a few years after the explosions (https://ibn.fm/Lm1dd). But Odyssey is now spearheading efforts to understand the condition and develop treatments for concussion, which until now, does not have an FDA-approved drug. Odyssey is developing the PRV-002, a novel compound for the treatment of concussion. The drug is currently undergoing evaluations as part of a Phase I clinical trial. Upon completing the Phase 1 trial, presenting its findings to the FDA for review, and after receiving positive feedback, Odyssey intends to initiate a Phase II clinical trial in the U.S., starting with the military. This is where the Military Advisory Board will play a crucial role. The board comprises Major General USA (r) and Former Chief of Staff USSOCOM James Linder, Commanding General U.S. Army Special Operations Command (r) Francis Beaudette, Lieutenant Colonel (r) Paul Toolan, and Vice Admiral (r) Timothy Szymanski, leaders who understand firsthand the consequences of TBI on the battlefield as well as its impacts on retired and separated service members. They equally recognize the role leaders at all levels have to play to protect the comprehensive brain health of their soldiers and the underlying need to passionately and aggressively pursue treatment. “Too many service members and veterans are suffering from post-concussive events, while their families are suffering as they watch and provide care. There remains an urgent need for a concussion treatment at the point of injury that immediately treats the initial injury, speeds recovery, and potentially diminishes its long-term effects. We are obligated to pursue treatments that improve a service member’s, and their families’, well-being through their service commitment and beyond,” commented Vice Admiral (r) Timothy Szymanski (https://ibn.fm/hHCeO). For more information, visit the company’s website at https://odysseygi.com/. NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY

Home Bistro Inc. (HBIS) Sees Triple-Digit Revenue Growth, Success in Meal-Delivery Platform

  • The company’s latest financial report shows a record revenue increase of 127%
  • Company anticipates continued record top-line growth
  • HBIS is making significant strides in efforts to increase its gross profit margin, decrease operating expenses to close the gap to profitability; positive earnings are expected in 2023
The market for online meal delivery is booming, as evidenced by triple-digit revenue growth reported by Home Bistro (OTC: HBIS), a leading online meal-delivery platform that offers exclusive celebrity chef-inspired, gourmet and lifestyle ready-made meals. The company’s latest financial report shows a record revenue increase of 127% over the same period the year before (https://ibn.fm/FqHzP). “With more chefs coming online earlier this fiscal year, we are continuing to see record top line growth,” stated Home Bistro CEO Zalmi Duchman. “As I have previously stated, our goal is to continue growing our revenue at a significant rate while eyeing profitability by 2023. To this end, over the past few months we have been taking significant steps to increase our profit margin and considerably decrease our general and administrative expenses.” HBIS released Q2 2022 financial information for the quarter ended April 30, 2022, including revenue highlights and an update on the company’s focus on strategic financial management. The report shows that product sales for the quarter increased 127% to $743,263, compared to revenues of $328,024 for the same period in 2021. The company noted that the increase was linked to its integration of the Model Meals brand along with consistent product sales from celebrity chefs Cat Cora and Daina Falk and the launch of Claudia Sandoval and Richard Blais. The company has also made significant efforts to control operating expenses and net loss. “In order to accomplish this, we have undertaken multiple initiatives,” said Duchman. “First, we have significantly reduced minimum guaranteed royalty payments to new celebrity chefs, and older, more costly guaranteed deals will begin to expire in 2023.” The company anticipates adding three more celebrity chefs and two add-on partnership offerings in the coming weeks. In addition, Duchman noted that the company is taking steps to reduce its product costs and retail prices, which will have a positive net effect on gross margin. Finally, “our recently announced collaboration with public relations firm Alab Group should benefit us by offsetting more expensive online advertising costs with a less costly but equally, if not more effective, influencer-based strategy,” he said. “We have grown as a publicly traded company over the past several years, and as we continue to work toward a potential Nasdaq uplisting, we will be significantly less reliant on costly external consultants and other professional service providers,” he continued. “Lastly, having just launched our subscription-based Model Meals program, we believe we can experience a much smoother path to a recurring revenue model, which we also plan to introduce for our Home Bistro and celebrity-chef brands in the near future.” Home Bistro is a leading online platform that provides for the creation, production and distribution of direct-to-consumer, heat-to-eat, celebrity-chef-inspired gourmet meals. Current HBIS offerings ceom from Iron Chef Cat Cora, Ayesha Curry, Hungry Fan Chef Daina Falk, Master Chef Claudia Sandoval, Top-Chef All-Star Richard Blais, and celebrity pastry and dessert chef Melanie Moss; celebrity chefs Roblé Ali and Priyanka Naik are set to add their selections soon. Home Bistro’s Model Meals lifestyle brand is a Whole30 and Paleo approved, ready-to-eat, meal-prep service, offering a weekly rotating menu that is prepared by professional chefs, using only the highest-quality ingredients available, sourced responsibly and locally, and delivered in sustainable, ecofriendly packaging. For more information, visit the company’s website at www.HomeBistro.com. NOTE TO INVESTORS: The latest news and updates relating to HBIS are available in the company’s newsroom at https://ibn.fm/HBIS

Sycamore Entertainment Group Inc. (SEGI) Is ‘One to Watch’

  • Sycamore Entertainment Group Inc., through subsidiary SEGI.TV, offers a streaming experience built on the pillars of equality, sustainability and community
  • SEGI.TV is scheduled to reach 100 million U.S. household televisions and 200 million mobile devices through Roku, Amazon Fire TV, Apple TV, Samsung Smart TV and others
  • Sycamore has entered sponsorship agreements for multiple motorsports events in an effort to connect with global influencers and build brand awareness
  • Ad-supported video on demand revenues are predicted to more than double between 2018 and 2024 to reach $56 billion across 138 countries
Sycamore Entertainment Group (OTC: SEGI) is a diversified entertainment company specializing in the acquisition, marketing and worldwide distribution of quality finished feature-length motion pictures. Through wholly owned subsidiary SEGI.TV, the company offers a streaming experience built on the pillars of equality, sustainability and community. SEGI.TV taps into the changing cultural environment, offering movies and television programming for a diverse audience – all without a subscription fee. SEGI.TV Launched in late 2020, SEGI.TV is scheduled to reach 100 million U.S. household televisions and 200 million mobile devices through Roku, Amazon Fire TV, Apple TV, Samsung Smart TV and others. The OTT streaming network operates via an ad-supported video on demand (“AVOD”) model, allowing Sycamore to control revenue growth by negotiating rates with advertisers as its userbase continues to expand. The company expects this AVOD model to help SEGI.TV more efficiently grow its market share while avoiding direct competition with subscription service players such as Netflix and Hulu. Other industry players who have leveraged and grown through the ad-based revenue model include Tubi (33 million monthly users, acquired by Fox), YouTube (2 billion monthly users, acquired by Google) and Pluto TV (28 million monthly users, acquired by NBC/Viacom). SEGI.TV lives up to its brand promise of inclusion, equality and community by: Attracting Original/Hard-to-Find Content SEGI.TV features uplifting content aimed at helping its users tap into the changing cultural environment, including movies, TV and sporting events, and the company continues to seek-out new and engaging programming. On March 19, 2022, SEGI.TV streamed the long-awaited grudge match between Hafthor Bjornsson and Eddie Hall, former World’s Strongest Men. Deemed ‘The Heaviest Boxing Match in History’, the bout was available to watch in just two clicks for free, without any time-specific trials, paywalled content or sneaky subscriptions. In speaking about the match, Sycamore CEO Edward Sylvan stated, “With live streaming sports revenues expected to quadruple by 2028, we at SEGI.TV are uniquely positioned to capitalize on this new ad supported model.” Making Inroads with New Users As consumers continue to shift away from traditional cable and satellite toward OTT streaming, existing options are divided into two primary categories – ad-supported and premium. While industry giants like Netflix, Disney and Apple target customers with non-ad-supported options, SEGI.TV’s AVOD model positions it as a solid alternative for individuals who are reluctant to commit to a subscription-based platform. Increasing Viewership through Branding and Awareness Sycamore has entered sponsorship agreements for multiple motorsports events in an effort to connect with global influencers and build brand awareness.
  • SEGI.TV sponsored the No. 10 Dallara-Honda of Alex Palou when he took the checkered flag, winning the Honda Indy Grand Prix of Alabama at Barber Motorsports Park.
  • SEGI.TV sponsored the No. 50 car of Floyd Mayweather’s TMT Racing for NASCAR’s Coca-Cola 600 at Charlotte Motor Speedway.
  • SEGI.TV sponsored the No. 99 SEGI.TV GMC HUMMER EV.R in the Extreme E all-electric global racing series, which focuses on bringing awareness to environmental and equality issues worldwide.
  • SEGI.TV has the North American broadcast right to the all-electric eSkootr Championship
Market Opportunity The gradual move away from traditional cable and satellite TV subscriptions in the U.S. and around the world has created an opportunity for streaming companies to capitalize. According to data from Statista, the number of pay TV households in the U.S. declined from a peak of 100.5 million in 2014 to roughly 73 million in 2021. Likewise, pay TV revenue in the U.S. decreased from $104 billion in 2015 to $74 billion in 2021. The loss for cable and satellite providers has corresponded with a boom for video-on-demand services. Subscription video-on-demand (“SVOD”) revenue in the U.S. reached $25 billion in 2021. According to Digital TV Research, AVOD revenues are predicted to more than double between 2018 and 2024 to reach $56 billion across 138 countries. Even SVOD mainstay Netflix is exploring AVOD as a way to combat declining subscription numbers. As Sycamore continues to expand SEGI.TV with new, unique and eventually premium content, it is uniquely positioned to benefit from this industry trend. Through its FAST (Free Ad-Supported TV) channels, SEGI.TV positions Sycamore as one of only a handful of publicly traded, pure play companies operating in the space. In an October 2021 report, Variety called FAST “the latest avenue for established media and entertainment companies,” and recent moves by entertainment mainstays support this notion. In April 2022, Amazon rebranded its FAST-focused AVOD service to Amazon Freevee and highlighted the rapid growth of the platform, which has tripled its monthly active users. “Advertising video-on-demand (‘AVOD’) and free ad-supported TV (‘FAST’) channels are the biggest winners of the Streaming Wars, we believe, because ‘free’ always has the largest TAM (total addressable market),” Laura Martin, an analyst with equity research firm Needham, said in a recent note to clients. Management Team Edward Sylvan is the CEO and Co-Founder of Sycamore. He has more than 30 years’ experience in the financial service and banking industry. His banking expertise helped cultivate more than 20 years of entertainment industry relationships. Terry Sylvan is the company’s CMO and Co-Founder. He brings to Sycamore more than 25 years of marketing and advertising experience, from global brand assignments to film marketing. For more information, visit the company’s website at www.SycamoreEntertainment.com. NOTE TO INVESTORS: The latest news and updates relating to SEGI are available in the company’s newsroom at https://ibn.fm/SEGI

From Our Blog

Canada Crypto Week Returns July 20–26, 2026, Turning Toronto into a Global Hub for Web3 and AI

July 8, 2026

Canada Crypto Week is back. Now in its sixth year, the week-long Web3 takeover of Toronto will run July 20–26, 2026, drawing builders, investors, founders, and community members from around the world for one of the most concentrated gatherings of Web3 activity on the global calendar. At the center of Canada Crypto Week is Blockchain […]

Rotate your device 90° to view site.